Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

223
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
223
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

8.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
8.0K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

2.1K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
2.1K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

12.0K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
12.0K
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

600
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
600
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

51
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
51

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

[Association between genetic polymorphism of tumor necrosis factor and chronic severe hepatitis B in patients].

Zhonghua yi xue za zhi·2007
Same author

In vivo translational inaccuracy in Escherichia coli: missense reporting using extremely low activity mutants of Vibrio harveyi luciferase.

Biochemistry·2007
Same author

[Construction of recombinant adenovirus vector expressing extracellular domain of TbetaR-II-RANTES fusion gene and its anti-tumor effects].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2007
Same author

[Characteristics, evolution and variation of M genes of human avian H5N1 strains in Guangdong].

Bing du xue bao = Chinese journal of virology·2007
Same author

Dynamic changes in microbial activity and community structure during biodegradation of petroleum compounds: a laboratory experiment.

Journal of environmental sciences (China)·2007
Same author

Differences in optical transport properties between human meridian and non-meridian.

The American journal of Chinese medicine·2007

相关实验视频

Updated: Mar 14, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K

分子驱动的多视图超图对比学习用于药物相互作用预测.

Xinyu Li, Ruijie Li, Qiao Ning

    IEEE transactions on computational biology and bioinformatics
    |March 12, 2026
    PubMed
    概括

    本研究介绍了Mol-HCL,这是通过分析内部分子结构来预测药物相互作用 (DDI) 的新框架. 通过整合多视图超图对比学习,Mol-HCL显著提高了DDI预测的准确性.

    科学领域:

    • 计算化学是一种计算化学.
    • 生物信息学是一种生物信息学.
    • 药理学 药理学是指药理学的学科.

    背景情况:

    • 药物组合可能导致不良反应,需要准确的药物相互作用 (DDI) 预测.
    • 现有的DDI预测方法往往侧重于表面的分子特征,忽视了关键的内部结构信息.

    研究的目的:

    • 提出Mol-HCL,一个多视图超图对比学习框架,用于增强DDI预测.
    • 为了利用内部分子结构信息进行更准确的DDI预测.

    主要方法:

    • 开发了一个多视图超图对比学习框架 (Mol-HCL),具有分子,结构和语义视图.
    • 嵌入超节点和超链以捕捉复杂的分子内和分子间关系.
    • 利用结构/语义超图和分子视图之间的对比学习来完善药物表示.

    主要成果:

    • 在DDI预测任务中,Mol-HCL与现有方法相比显示出显著的改进.
    • 该框架有效地捕获用于DDI分析的分子内和分子间信息.
    • 在两个真实世界数据集上的实验验证证证了拟议方法的有效性.

    结论:

    • 通过分析内部分子结构,Mol-HCL为DDI预测提供了一种强大的新方法.

    更多相关视频

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    12.8K
    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    19.7K

    相关实验视频

    Last Updated: Mar 14, 2026

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.7K
    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    12.8K
    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    19.7K
  • 多视图超图对比学习策略提高了DDI预测的准确性和稳定性.
  • 这一框架为潜在的药物组合风险提供了有价值的见解.